Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Triomics is a specialized healthcare technology company that leverages generative AI and large language models to accelerate oncology clinical trials. The company's platform automates complex tasks such as patient matching, clinical data extraction from unstructured electronic health records, and trial recruitment workflows. By integrating directly with hospital systems, Triomics enables cancer centers to significantly reduce the manual effort required to identify eligible patients for research studies. Their technology is designed to improve the efficiency of clinical research and expand access to precision medicine for oncology patients. The company primarily serves academic medical centers and large health systems to streamline their research operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Triomics.